May. 18, 2023 Sysmex Corporation will launch its Clinical Flow Cytometry1 System Flow Cytometer XF-1600, Sample Preparation System PS-10, antibody reagents, and other. | June 11, 2023
SINGAPORE, Dec. 1, 2022 /PRNewswire/ MGI Tech Co. Ltd. (MGI), a company committed to building core tools and technology to lead life science, will join global and Asian cancer professionals at the ESMO Asia Congress 2022 taking place 2-4 December in Singapore. In addition, MGI will introduce a free trial campaign on its latest sequencer DNBSEQ-G99 for early users in APAC at the event(more details can be found here). At ESMO, MGI sets to showcase its MGISP-100 Automated Sample Preparation System and DNBSEQ-G99 Genetic Sequencer at Booth C209. Suitable for small and medium-sized research laboratories such as in hospitals, MGISP-100 provides an automated library package for the most popular applications such as breast cancer, lung cancer and more. Meanwhile, as one of the fastest sequencers among medium-to-low throughput sequencers globally, DNBSEQ-G99 was developed based on MGI's proprietary DNBSEQ technology and further enabled by innovations in biochemistry, optics, fluidics,